Home › NDC Lookup › RxCUI directory › RxCUI 2725542

2.67 ML furosemide 30 MG/ML Cartridge — RxCUI 2725542

RxNorm drug concept · Semantic clinical drug
RxCUI 2725542 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2725542
Official name2.67 ML furosemide 30 MG/ML Cartridge
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfurosemide 80 MG per 2.67 ML Cartridge; furosemide 80 MG in 2.67 ML Cartridge
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Furosemide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Injectable furosemide is used when you need faster action than a pill can provide, or when you can't take oral medication — for example, in an emergency like acute pulmonary edema...
  • Why am I getting this as an injection instead of a pill?
  • The biggest things to watch for are signs of dehydration — feeling very dizzy, lightheaded, or faint, especially when you stand up — and muscle cramps or weakness, which can signal...
  • What should I watch out for while using furosemide injection?
📖 Read our full Furosemide Injection guide →

🕸️ Concept Web — How 2.67 ML furosemide 30 MG/ML Cartridge Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2.67 ML furosemide 30 MG/ML Cartridge RxCUI 2725542

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Furosemide 4603
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lasix 202991
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Furosemide Cartridge 2621021
    • Furosemide Injectable Product 1162712
    • Furosemide Cartridge [Lasix] 2725545
    • Lasix Injectable Product 1175645
    • Cartridge 1649572
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Furosemide 30 MG/ML SCDC · 2725541
  • Furosemide Cartridge SCDF · 2621021
  • Furosemide Injectable Product SCDG · 1162712

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2725542 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
81137-0001-15 1 CARTON in 1 KIT (81137-001-15) / 1 CARTRIDGE in 1 CARTON... LASIX ONYU SQ Innovation, Inc. 2025-12-01
81137-0001-35 3 CARTON in 1 KIT (81137-001-35) / 1 CARTRIDGE in 1 CARTON... LASIX ONYU SQ Innovation, Inc. 2026-06-15
Observed labelers: SQ Innovation, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.